Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epidural esketamine after cesarean section for postpartum depression and postoperative analgesia
ChiCTR2400093104Phase 4Completed
- Sponsor
- Yancheng First People's Hospital
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine in postpartum depression (PPD) (2 arms), sponsored by Yancheng First People's Hospital. Primary endpoint: Occurrence of postpartum depression assessed by Edinburgh Postnatal Depression Scale. Started Nov 2024; status: completed.
02
Drugs
esketamine
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on ChiCTR2400093104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093104.